List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 86 studies with search of: "Latanoprost"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed A Study Demonstrating the Effect of Latanoprost in Combination With Timolol, Latanoprost Alone and Timolol Alone on Eye Pressure in Open Angle Glaucoma or Ocular Hypertension in Patients
Conditions: Ocular Hypertension;   Glaucoma;   Open-Angle Glaucoma
Interventions: Drug: i. Fixed combination of latanoprost 0.005% and timolol 0.5%;   Drug: timolol 0.5% ophthalmic solution;   Drug: latanoprost 0.005% ophthalmic solution
2 Active, not recruiting Comparison of Bimatoprost and Latanoprost in Patients With Chronic Angle-Closure Glaucoma: A Randomized Cross-Over Study
Condition: Glaucoma, Angle-Closure
Interventions: Drug: Latanoprost-Bimatoprost;   Drug: Bimatoporost-Latanoprost
3 Completed Brimonidine 0.1% Versus Brinzolamide 1% as Adjunctive Therapy to Latanoprost 0.005%
Conditions: Glaucoma;   Ocular Hypertension
Interventions: Drug: latanoprost 0.005% eye drops and brimonidine 0.1% eye drops;   Drug: latanoprost 0.005% eye drops and brinzolamide 1.0% eye drops
4 Completed Pressure Reduction Effect in Patients With Glaucoma Who Used Xalatan and Cosopt
Condition: Glaucoma
Interventions: Drug: dorzolamide hydrochloride (+) timolol maleate (Cosopt);   Drug: Comparator: latanoprost (Xalatan)
5 Recruiting Effects of Latanoprost on Choroidal Blood Flow Regulation in Human Subjects
Conditions: Ocular Physiology;   Intraocular Pressure;   Regional Blood Flow
Interventions: Drug: Latanoprost 0.005%, Xalatan®;   Drug: Placebo
6 Recruiting A Phase 1, Open-Label Study of Latanoprost Acid Plasma Concentrations in Pediatric and Adult Glaucoma Patients Treated With Latanoprost.
Conditions: Glaucoma;   Ocular Hypertension
Intervention: Drug: latanoprost
7 Recruiting Effect of Age on Latanoprost 0.005% in Patients With Glaucoma
Condition: Glaucoma
Intervention: Drug: Latanoprost 0.005%
8 Completed Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-Weeks, Masked Evaluator, Phase IV Multi-Center Study in the US
Conditions: Glaucoma;   Ocular Hypertension
Interventions: Drug: latanoprost 0.005% ophthalmic solution;   Drug: Travoprost 004% sterile ophthalmic solution;   Drug: Bimatoprost .03% sterile ophthalmic solution
9 Active, not recruiting 24-hr IOP With Travoprost/Timolol Compared With Latanoprost/Timolol in XFG
Condition: Glaucoma
Interventions: Drug: treatment with latanoprost/timolol fixed combination;   Drug: latanoprost/timolol fixed combination drops
10 Active, not recruiting Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Latanoprost (Xalatan);   Drug: Bimatoprost (Lumigan)
11 Recruiting Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure.
Conditions: Primary Open-Angle Glaucoma;   Ocular Hypertension
Interventions: Drug: PF-04217329--High Dose;   Drug: PF-04217329--Low Dose;   Drug: PF-04217329--Medium Dose;   Drug: Xalatan;   Drug: vehicle;   Drug: High Dose PF-04217329 and Xalatan;   Drug: Low Dose PF-04217329 and Xalatan;   Drug: Medium Dose PF-04217329 and Xalatan
12 Active, not recruiting Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular Hypertension
Conditions: Ocular Hypertension;   Glaucoma
Interventions: Drug: bimatoprost 0.03% eye drops;   Drug: latanoprost 0.005% eye drops
13 Completed A Study of Glaucoma or Ocular Hypertension in Patients Within the United States
Conditions: Ocular Hypertension;   Glaucoma
Interventions: Drug: latanoprost 0.005%;   Drug: fixed combination latanoprost-timolol;   Drug: timolol 0.5%
14 Completed 24-Hour Intraocular Pressure (IOP) Control With Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combination in Open-Angle Glaucoma
Condition: Open-Angle Glaucoma
Interventions: Drug: Drug: dorzolamide/timolol;   Drug: Drug: latanoprost/timolol;   Drug: dorzolamide/timolol and latanoprost;   Drug: placebo (artificial tears)
15 Recruiting The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye
Conditions: Glaucoma;   Periocular Skin Pigmentation Changes
Interventions: Drug: Latanoprost;   Drug: Bimatoprost;   Drug: Travoprost
16 Active, not recruiting Safety and Efficacy of Punctum Plug Delivery System in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Conditions: Glaucoma;   Ocular Hypertension
Interventions: Drug: Latanoprost-PPDS;   Drug: Latanoprost-PPDS;   Drug: Latanoprost-PPDS
17 Active, not recruiting Comparison of Latanoprost Vs. Timolol
Condition: Glaucoma
Interventions: Drug: Latanoprost;   Drug: Timolol
18 Recruiting Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Conditions: Retina;   Ocular Physiology
Interventions: Drug: latanoprost 0.005% + timolol 0,5% fixed combination;   Drug: brimonidine 0,2% + timolol 0,5% fixed combination
19 Active, not recruiting Efficacy, Tolerability and Safety of RKI983 (0.05% & 0.10%) vs Xalatan in Patients With POAG or Ocular Hypertension
Conditions: Glaucoma;   Ocular Hypertension
Interventions: Drug: RKI983A;   Drug: RKI983A;   Drug: Latanoprost
20 Completed Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension.
Conditions: Ocular Hypertension;   Glaucoma, Open-Angle
Intervention: Drug: latanoprost 0.005% (Xalatan)

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services